DENTSPLY SIRONA (XRAY) Restructuring Push Keeps Undervalued Case In Play
DENTSPLY SIRONA (XRAY) is in focus after management highlighted a restructuring program targeting about $120 million in annual cost savings, with the company directing that firepower toward digital dentistry and R&D investments.
Recent trading has been choppy for DENTSPLY SIRONA, with the share price down 13.51% over the past 30 days and the year-to-date share price return declining 15.35%, while the 1-year total shareholder return has fallen 25.50%, which points to fading momentum despite the restructuring push.
Scan beyond DENTSPLY SIRONA and compare its restructuring story with other potential turnaround candidates in the 16 high quality undiscovered gems.
DENTSPLY SIRONA has cut costs and refocused on digital tools, yet the share price has already fallen hard. Is more upside still ahead, or has most of the easy rerating already happened?
Most Popular Narrative: 29% Undervalued
Analysts following DENTSPLY SIRONA see a fair value of $13.40 per share, compared with the recent close at $9.54. This frames the current pricing as a sizable discount and puts the focus firmly on whether execution can close that gap.
Active cost reduction programs, operational streamlining, and supply chain optimization are in progress, with management indicating a stronger urgency to go "deeper and faster." This may potentially boost EBITDA margin and cash flow generation through both lower SG&A and more efficient manufacturing.
See why 10 investors see DENTSPLY SIRONA as 29% undervalued.
Result: Fair Value of $13.40 (UNDERVALUED)
Still, the narrative around DENTSPLY SIRONA can break quickly if tariff costs continue to pressure margins or if weakness in elective procedures for implants and CAD/CAM persists.
Find out about the key risks to this DENTSPLY SIRONA narrative.
Next Steps
If this DENTSPLY SIRONA story sounds optimistic to you, consider acting promptly and evaluate that sentiment against the underlying numbers yourself. Begin with a clear view of the 4 key rewards.
Looking for more investment ideas beyond DENTSPLY SIRONA?
Do not stop with DENTSPLY SIRONA. Put that curiosity to work and let a focused stock screener surface opportunities you might not spot on your own.
- Target potential upside by scanning a curated pool of companies trading at what may be appealing valuations through the 33 high quality undervalued stocks.
- Prioritise resilience by filtering for businesses with stronger finances and healthier balance sheets using the list of solid balance sheet and fundamentals (23 results).
- Lock in potential income ideas by zeroing in on companies offering higher yields and robust payouts through the 6 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com